SIREN : 403286446
PHARMASTOCK is a French company founded 30 years ago, specialized in the sector Entreposage et stockage non frigorifique. Based in BOULOGNE-BILLANCOURT (92100), this company of category ETI shows in 2024 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 094 426 € | 1 211 564 € | 1 377 450 € | 1 540 601 € | 1 447 178 € | 1 409 497 € | 1 533 525 € | 1 576 738 € | 1 423 085 € |
| Net income | -105 320 € | 4 651 € | 56 730 € | 69 156 € | -122 406 € | -82 790 € | 21 902 € | 84 217 € | -13 098 € |
| EBITDA | 144 049 € | 248 139 € | 237 147 € | 290 670 € | 109 961 € | 165 064 € | 203 718 € | 241 614 € | -246 717 € |
| Net margin | -9.6% | 0.4% | 4.1% | 4.5% | -8.5% | -5.9% | 1.4% | 5.3% | -0.9% |
In 2024, PHARMASTOCK achieves revenue of 1.1 M€. Activity remains stable over the period (CAGR: -3.2%). Slight decline of -10% vs 2023. After deducting consumption (12 k€), gross margin stands at 1.1 M€, i.e. a rate of 99%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 144 k€, representing 13.2% of revenue. Warning negative scissor effect: despite revenue change (-10%), EBITDA varies by -42%, reducing margin by 7.3 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Net income is negative at -105 k€ (-9.6% of revenue), which will impact equity.
1 094 426 €
1 082 757 €
144 049 €
-78 548 €
-105 320 €
13.2%
The debt ratio (= Financial debt / Equity x 100) stands at 269%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.1 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 10.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
268.521%
20.459%
10.661%
6.117
21.4%
In 2024, the debt ratio of PHARMASTOCK (268.52) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2024, the financial autonomy of PHARMASTOCK (20.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of PHARMASTOCK (6.12) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 183.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 13.4x. Operating income very largely covers interest expenses: high safety margin.
183.775
13.359
In 2024, the liquidity ratio of PHARMASTOCK (183.78) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of PHARMASTOCK (13.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 101 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 58 days. The gap of 43 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 1 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 85 days of revenue, i.e. 258 k€ to permanently finance.
257 934 €
101 j
58 j
1 j
85 j
Based on 77 transactions of similar company sales
(all years),
the value of PHARMASTOCK is estimated at
150 508 €
(range 78 623€ - 357 438€).
With an EBITDA of 144 049€, the sector multiple of 1.0x is applied.
The price/revenue ratio is 0.14x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 77 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHARMASTOCK with other companies in the same sector:
Voir toutes les statistiques du secteur Entreposage et stockage non frigorifique
The revenue of PHARMASTOCK in 2024 is 1.1 M€.
PHARMASTOCK recorded a net loss in 2024.
The headquarters of PHARMASTOCK is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.
The tax return of PHARMASTOCK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHARMASTOCK operates in the sector Entreposage et stockage non frigorifique (NAF code 52.10B). See the 'Sector positioning' section above to compare the company with its competitors.